Frost & Sullivan’s Summit on Global Life Science Molecules: Emerging Opportunities

There is no stopping the global life sciences industry. With worldwide sales of drugs crossing $500 billon, manufacturers are increasingly spending on research & development (R&D), and implementing successful strategies to acquire a greater share of this expanding industry. “New drug discovery”, “biopharmaceutical research”, “custom synthesis”, and “strategic outsourcing” are the latest industry buzzwords. In such a competitive scenario, the Indian pharmaceutical market has shown rapid growth over the years, and has established itself in the global arena. Indian fine chemical and drug manufacturers are establishing themselves as participants to be reckoned with.

[ClickPress, Tue Mar 29 2005] In order to understand the relevant and strategic issues of the growing symbiotic relationship between global and Indian fine chemical and drug manufacturers, Frost & Sullivan is hosting a three-day international conference titled “Global Life Science Molecules: Emerging Opportunities,” from 3rd-5th of June, 2005, in Goa, one of the most exotic and multicultural states in India. This is a conclave of great thinkers, strategic decision makers, and corporate heads of the leading pharmaceutical fine chemical companies. It is an ideal platform for international companies to network with each other, and with leading Indian manufacturers.

This conference will focus on recent developments in the global active pharmaceutical ingredients (API)/intermediate industry in the key areas of R&D, strategic partnerships, manufacturing excellence & methodologies, and marketing strategies. On the first two days of the conference, international stalwarts and decision makers from leading companies such as Lonza Group Ltd, DSM Pharma Chemicals, Cambrex Corporation, LANXESS, and Teva Pharmaceutical Industries, will share their knowledge and address business issues on various topics.

These topics will cover relevant themes such as the opportunities that exist in outsourcing, technology licensing and contract research, critical factors considered for partner selection, opportunities for emerging technologies in drug manufacturing, and strategies for global leadership. These will be interspersed with panel discussions addressing the most relevant issues of the industry.

A scenic location such as Goa would be an ideal venue for a conference of such magnitude. It provides the much-needed blend of business interactions in a relaxed setting. The last day of the conference would involve informal meetings, interactive sessions, and golf.

“We certainly believe that the conference will offer the ideal networking platform for our international speakers and delegates from India and abroad, thereby creating opportunities for business synergies within the industry,” says Mamta Wadhwa, Industry Manager, Chemicals, Materials and Foods Practice, Frost & Sullivan.

Advantages of Participating in the Conference:

•Opportunity to listen to the most relevant and current issues of the pharmaceuticals industry, presented by global leaders in the industry

•A chance to personally interact with key decision makers of global, leading fine chemicals and drug manufacturers, all under one roof, in a span of three days

•An ideal platform to talk shop and strike business deals with global participants

•Participating delegates get to receive free compendiums of Frost & Sullivan research services of their choice, from a list of recent studies on the industry

•Opportunity to understand key strategies that will help improve attendees’ performance in a competitive business environment

•A strategic setting for informal interactions, providing a good blend of business and relaxation

About Frost & Sullivan - Founded in 1961 in New York, Frost & Sullivan is a global growth consulting company, supporting clients' expansion for more than four decades. In India, our market expertise covers a broad spectrum of verticals (technology, healthcare, automotive, chemicals, industrial and process consulting) while our portfolio of advisory competencies includes custom strategic consulting, market intelligence, summits & conferences and management training. Our mission is to forge partnerships with our clients' management teams to deliver market insights and to create value and drive growth through innovative approaches.
Frost & Sullivan's network of consultants and analysts spans the globe with offices in every major country.

Bookmark this release: Del.icio.us - Digg - Furl - Blinklist - Reddit